Total planned funding: $571,773,896
Clear active filters
Not Available
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
South Africa | $87,854,639 |
Nigeria | $83,754,901 |
Cameroon | $58,452,631 |
Tanzania | $49,228,566 |
Kenya | $43,449,497 |
Asia Regional Program | $42,500,000 |
Haiti | $36,989,157 |
Uganda | $30,198,922 |
Zambia | $17,339,553 |
South Sudan | $16,331,489 |
Zimbabwe | $12,211,012 |
Ukraine | $9,879,381 |
Burundi | $8,629,493 |
Democratic Republic of the Congo | $7,842,732 |
Mozambique | $7,502,413 |
West Africa Region | $7,063,568 |
Vietnam | $6,829,175 |
Botswana | $6,430,000 |
Malawi | $4,830,291 |
Ethiopia | $4,667,035 |
Cambodia | $4,659,203 |
Dominican Republic | $4,253,345 |
Ghana | $4,200,000 |
Central Asia Region | $3,800,000 |
India | $2,850,000 |
Namibia | $2,557,794 |
Lesotho | $2,240,000 |
Central America Region | $2,080,931 |
Côte d'Ivoire | $1,329,221 |
Rwanda | $470,000 |
Western Hemisphere Region | $421,947 |
Eswatini | $402,000 |
Angola | $375,000 |
Caribbean Region | $150,000 |
Indonesia | $0 |
Program Areas
Governance and Systems | $201,427,866 |
Prevention | $117,767,735 |
Treatment | $109,250,301 |
Care | $108,588,073 |
Testing | $42,979,259 |
Budget Codes
OHSS: Health Systems Strengthening | $159,756,736 |
HTXS: Treatment: Adult Treatment | $101,069,478 |
HKID: Care: Orphans and Vulnerable Children | $78,510,756 |
HVOP: Sexual Prevention: Other Sexual Prevention | $48,269,636 |
HVCT: Testing: HIV Testing and Counseling | $42,979,259 |
HVSI: Strategic Information | $31,112,134 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $26,878,389 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $22,682,490 |
HBHC: Care: Adult Care and Support | $20,623,220 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $14,236,016 |
HLAB: Laboratory Infrastructure | $10,558,996 |
HVTB: Care: TB/HIV | $6,522,235 |
PDTX: Treatment: Pediatric Treatment | $5,980,823 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,159,940 |
PDCS: Care: Pediatric Care and Support | $2,931,862 |
HTXD: Treatment: ARV Drugs | $2,200,000 |
HMBL: Biomedical Prevention: Blood Safety | $1,500,000 |
HMIN: Biomedical Prevention: Injection Safety | $41,264 |